Agree that hernia mesh products is a crowded space and we would definitely have to produce or market a product with a point of difference that differentiates us from the rest in a crowded room - that's the point with BTM is that it is NOT a biological, is less prone to infections etc and can be used in a wide variety of situations, with the next generation of products ie MTX now starting to come through. Having said that, I assume the same holds for breast slings and associated products, and yes I am aware of our previous uneventful partnerships with Establishment Labs, however given the same applies, do you think that it would be worth considering trying to link up again with another producer of breast implants to create a 'system' that could be offered to offset the time/money/work to break into the market from a stand still? Could a package of many parts - not all being Polynovo products - be created to get leverage into the breast implant and reconstruction market?
- Forums
- ASX - By Stock
- PNV - Banter and General Comments
Agree that hernia mesh products is a crowded space and we would...
-
-
- There are more pages in this discussion • 4,171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.32 |
Change
-0.020(0.85%) |
Mkt cap ! $1.602B |
Open | High | Low | Value | Volume |
$2.35 | $2.37 | $2.30 | $2.354M | 1.012M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 11423 | $2.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.33 | 8018 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2647 | 2.310 |
8 | 40821 | 2.300 |
3 | 112620 | 2.290 |
6 | 42871 | 2.280 |
4 | 9452 | 2.270 |
Price($) | Vol. | No. |
---|---|---|
2.340 | 2032 | 1 |
2.350 | 9974 | 2 |
2.360 | 39170 | 3 |
2.370 | 2032 | 1 |
2.380 | 1513 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |